Shire PLC

Shire PLC
Stock Exchange Other OTC
EPS
$5.26
Market Cap
$51.63 B
Shares Outstanding
914.55 M
Public Float
-
Shire PLC ADR
Stock Exchange Frankfurt Stock Exchange
EPS
EUR13.37
Market Cap
EUR44.57 B
Shares Outstanding
304.85 M
Public Float
-
Shire PLC
Stock Exchange London Stock Exchange
EPS
GBP3.95
Market Cap
GBP39.72 B
Shares Outstanding
914.55 M
Public Float
905.51 M
Shire PLC
Stock Exchange Mexican Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
304.85 M
Public Float
-
Shire PLC ADR
Stock Exchange NASDAQ Stock Market
EPS
$15.98
Market Cap
$51.63 B
Shares Outstanding
304.85 M
Public Float
304.8 M

Profile

Address
4-1-1 Dosho-machi
Osaka Osaka 540
Japan
Employees -
Website http://www.takeda.co.jp
Updated 07/08/2019
Shire Plc is a biopharmaceutical company. It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs. The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol.

Financials

View All

Thomas J. W. Dittrich
Chief Financial Officer & Director
Olivier Jean Bohuon
Non-Executive Director